Corticotropin releasing hormone (CRH) is produced in intrauterine site
s including the placenta, decidua, and myometrium during human pregnan
cy. Placental CRH may have endocrine, paracrine, and autocrine functio
ns. Its output into the maternal circulation increases as a function o
f gestation and correlates with increases in levels of mRNA encoding C
RH in placental syncytiotrophoblast. Regulation of placental CRH expre
ssion and activity is multifactorial, being inhibited by progesterone
and nitric oxide (NO), and stimulated by cytokines, neuropeptides, and
glucocorticoids. CRH acts as a vasodilator in perfused placental tiss
ue in vitro, may modulate maternal and fetal pituitary function, and h
as been implicated in mechanisms associated with the onset of labor at
term and preterm.